Alcanza Clinical Research Announces Strategic Acquisition of CNS Healthcare
Submit Your Information
Create a Profile
Get In Touch Mobile
Daniel Brune
Daniel Brune, M.D.
Dr. Daniel Brune is a Board-Certified Internist with over three decades of clinical and research experience. Since 1988, he has demonstrated a deep commitment to vaccine development, having participated in 75 early-phase vaccine trials. Licensed in Illinois as a Physician & Surgeon and holding a Controlled Substance Registration, Dr. Brune has served as Principal Investigator in more than 100 clinical trials spanning a wide range of therapeutic areas, including cardiovascular, endocrine/metabolic, gastrointestinal, neurology, psychiatry, pulmonary, urology, dermatology, and men’s health, as well as medical device studies. He is also a published co-author of a phase III influenza vaccine study featured in the Journal of Infectious Diseases.
Articles
Alcanza Clinical Research Announces Strategic Acquisition of CNS Healthcare
Jim Leary Joins Alcanza as Chief Information Officer
Alcanza Clinical Research Announces Launch of Enspire Clinical Research in Illinois
Ready to be part of healthcare history? Find the right clinical trial for you.
